SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-022517
Filing Date
2019-06-14
Accepted
2019-06-14 08:00:48
Documents
3
Period of Report
2019-06-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K urov-8k_20190613.htm 8-K 37748
2 EX-99.1 urov-ex991_6.htm EX-99.1 200084
3 GRAPHIC go5qmedvbvdd000001.jpg GRAPHIC 10310
  Complete submission text file 0001564590-19-022517.txt   253322
Mailing Address 5151 CALIFORNIA AVENUE SUITE 250 IRVINE CA 92617
Business Address 5151 CALIFORNIA AVENUE SUITE 250 IRVINE CA 92617 949-226-6029
Urovant Sciences Ltd. (Filer) CIK: 0001740547 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-38667 | Film No.: 19897598
SIC: 2834 Pharmaceutical Preparations